ArticleBMC nutrition2026
Effect of vitamin A supplementation and the role of infections and inflammation on vitamin A status in children aged 36-59 months in rural Burkina Faso: results of a community-based pre-post intervention study.
Article in BMC nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSeveral interventions are implemented in Burkina Faso to tackle vitamin A (VA) deficiency. This study assessed the effects of high-dose VA supplementation (VAS) on indicators of VA status in preschool children and examined whether infections and inflammation modified VA status post-supplementation.
methodsA community-based pre-post intervention study was conducted during the dry season in rural Burkina Faso among 60 children aged 36–59 months. After baseline assessment, each child received a high-dose oral VAS, and an endline assessment was performed one month later. VA total body stores (TBS), total liver reserve (TLR), and serum retinol concentrations were assessed. Effects of VAS were assessed using Student’s t-test for mean differences across time points (pre- and post-supplementation) and McNemar’s test for differences in proportions. Inflammation was defined as elevated concentrations of C-reactive protein (CRP) or α-1-acid glycoprotein (AGP) at any measurement point (Day 0 or Day 14, pre- or post-supplementation). Malaria infection was assessed at Day 0 during both study phases, and intestinal parasites were evaluated at baseline. Linear regression was used to test the modifying effects of infections and inflammation on VA status post-supplementation.
resultsNeither unadjusted nor adjusted serum retinol concentrations changed significantly following high-dose VAS. Although geometric mean ratios (GMRs) suggested modest, non-significant changes in VA TBS and TLR, the prevalence of hypervitaminosis A (TLR ≥ 1 µmol/g) significantly increased from 17% to 38% post-supplementation. Infections and inflammation did not significantly modify changes in VA status overall. However, the GMR for retinol at endline compared to baseline was 0.68 (95%CI: 0.51; 0.91) among children with elevated CRP, corresponding to a 32% reduction in retinol levels (p = 0.011).
conclusionsHigh-dose VAS resulted in limited effects on VA status among children whose baseline VA status was already adequate, as indicated by TBS and TLR. Infections and inflammation had minimal to no influence on VA indicators post-supplementation. Future studies should include larger samples and use comprehensive assessment tools to assess the full spectrum of VA status, from deficiency to hypervitaminosis, while accounting for a broader spectrum of infection risks. Such approaches will help better evaluate VA intervention strategies within the context of overlapping public health programs.
trial registrationRetrospective study registration as a clinical trial was done with the Pan African Clinical Trials Registry (Cochrane South Africa; PACTR201803002999356) on 22 March 2018.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.